Thema: US5588681057
MDGL, US5588681057
money-5372710_1920.jpg - Foto: THN
Madrigal Pharmaceuticals stock trades at 384.25 euros Friday
Madrigal Pharmaceuticals stock has its next scheduled event on November 3. The company plans to release third-quarter results that day.
ad-hoc-news.de, heute 18:41 Uhr
MDGL, US5588681057
BofA cuts target for Madrigal Pharmaceuticals stock to USD ...
Madrigal reports third-quarter results on November 3, 2026. Madrigal Pharmaceuticals stock costs EUR 394.95 on October 27, 2026 after hours in Europe.
ad-hoc-news.de, 27.10.26 18:42 Uhr
MDGL, US5588681057
UBS raises target for Madrigal Pharmaceuticals stock to ...
Results are due November 3, 2026. Madrigal Pharmaceuticals stock closed at USD 434.24 on October 23, 2026, down 4.21 percent on Nasdaq.
ad-hoc-news.de, 24.10.26 21:11 Uhr
MDGL, US5588681057
UBS raises target to USD 735 for Madrigal Pharmaceuticals ...
Madrigal reports third-quarter results November 3, 2026. Madrigal Pharmaceuticals stock costs EUR 416.35 on October 20, 2026 at 10:03 p.m. CEST.
ad-hoc-news.de, 20.10.26 22:07 Uhr
MDGL, US5588681057
UBS raises target to USD 735.00 for Madrigal Pharmaceuticals ...
UBS set F4 odds at 60.00 percent October 14, 2026. Madrigal Pharmaceuticals stock was USD 449.74 October 16, 2026, down 2.19 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 21:53 Uhr
MDGL, US5588681057
UBS lifts target for Madrigal Pharmaceuticals stock to USD ...
Madrigal's next earnings date is November 3, 2026. Madrigal Pharmaceuticals stock costs EUR 410.05 on October 15, 2026 at 10:03 p.m. CEST.
ad-hoc-news.de, 15.10.26 22:07 Uhr
MDGL, US5588681057
Madrigal Pharmaceuticals stock reports 71 percent revenue ...
Madrigal Pharmaceuticals stock had more than 49,000 Rezdiffra patients on June 30, 2026. The October 2 price was USD 499.40 after Q2 revenue rose 71 percent.
ad-hoc-news.de, 04.10.26 23:21 Uhr
Madrigal, Shares
Madrigal Shares Face Scrutiny Following Analyst Downgrade ...
